<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="4-part\PMC7290740\results\search\disease\results.xml">
  <result pre="BY) license (http://creativecommons.org/licenses/by/4.0/). Abstract Influenza virus infections can lead to" exact="viral pneumonia" post="and acute respiratory distress syndrome in severe cases, causing"/>
  <result pre="license (http://creativecommons.org/licenses/by/4.0/). Abstract Influenza virus infections can lead to viral" exact="pneumonia" post="and acute respiratory distress syndrome in severe cases, causing"/>
  <result pre="Abstract Influenza virus infections can lead to viral pneumonia and" exact="acute respiratory distress syndrome" post="in severe cases, causing significant morbidity and mortality and"/>
  <result pre="great threat to human health. Because of the diversity of" exact="influenza" post="virus strains and drug resistance to the current direct"/>
  <result pre="effective drugs as yet to cure all patients infected by" exact="influenza" post="viruses. Natural products from plants contain compounds with diverse"/>
  <result pre="as an inhibitor against the replication of a panel of" exact="influenza" post="A and B viruses both on human pulmonary epithelial"/>
  <result pre="and improves the survival rate of mice infected with lethal" exact="influenza" post="virus. Also, EEC treatment attenuated lung injury and reduced"/>
  <result pre="be further developed as a resource of new anti-influenza drugs." exact="influenza" post="virus caesalpinia decapetala antiviral extract 1. Introduction Despite the"/>
  <result pre="Introduction Despite the availability of vaccines and direct-acting antiviral drugs," exact="influenza" post="causes substantial morbidity and mortality every year [1]. Vaccination"/>
  <result pre="widespread drug-resistant strains, they are no longer recommended to treat" exact="influenza" post="[6]. Current therapy for influenza includes virus neuraminidase inhibitors"/>
  <result pre="no longer recommended to treat influenza [6]. Current therapy for" exact="influenza" post="includes virus neuraminidase inhibitors and polymerase inhibitors [7]. The"/>
  <result pre="which cannot shorten the course of the disease [11]. Since" exact="influenza" post="causes a huge burden on society every year in"/>
  <result pre="to develop new anti-influenza drugs against a broad spectrum of" exact="influenza" post="viruses, including the resistant strains [12]. Plants produce a"/>
  <result pre="extracted from Artemisia annua and has been used to treat" exact="malaria" post="[15]. To explore the potential of plant extracts in"/>
  <result pre="of the 600 plants in a U937 cell model against" exact="influenza" post="virus infection [16], we found that the ethanol extract"/>
  <result pre="of Caesalpinia decapetala (Roth) Alston (EEC) has antiviral activity against" exact="influenza" post="virus infection. Caesalpinia decapetala (Roth) Alston (C. decapetala) is"/>
  <result pre="as a folk medicine to prevent colds, treat bronchitis, and" exact="malaria" post="[20]. However, the extract of C. decapetala has never"/>
  <result pre="broad-spectrum inhibitory effect on the replication of all strains of" exact="influenza" post="viruses tested on Madin–Darby Canine Kidney (MDCK), A549, and"/>
  <result pre="could improve the survival rate of mice infected with lethal" exact="influenza" post="virus and decrease the virus titers and pathological damage"/>
  <result pre="amplified from 10-day-old chicken embryos. The virus titers of different" exact="influenza" post="strains were determined using 50% tissue culture infective dose"/>
  <result pre="the antiviral assay, cells were plated and infected with the" exact="influenza" post="virus in the presence or absence of the drug."/>
  <result pre="2′-(4-methylumbelliferyl)-a-D-N-acetylneuraminic acid (MUNANA, Sigma, M8639), for the neuraminidase (NA) of" exact="influenza" post="viruses was used to detect the levels of NA."/>
  <result pre="were anesthetized with pentobarbital sodium and then infected with the" exact="influenza" post="virus through the nasal cavity. Infected mice were treated"/>
  <result pre="extract of C. decapetala (EEC) inhibits the replication of the" exact="influenza" post="virus on A549 cells. As shown in Figure 1A,"/>
  <result pre="cells. As shown in Figure 1A, EEC inhibited the H1N1" exact="influenza" post="virus PR8 strain infection on A549 cells, with a"/>
  <result pre="At concentrations higher than 43 μg/mL, the production of infectious" exact="influenza" post="virions was below the detection limit (10 TCID50/mL). The"/>
  <result pre="to A549 cells. In conclusion, we demonstrated that EEC inhibits" exact="influenza" post="virus replication on A549 cells. 3.2. EEC Has a"/>
  <result pre="of Influenza Viruses in A549, U937, and MDCK Cells Human" exact="influenza" post="A and B viruses cause annual influenza epidemics, whereas"/>
  <result pre="MDCK Cells Human influenza A and B viruses cause annual" exact="influenza" post="epidemics, whereas influenza A viruses can also cause sporadic"/>
  <result pre="influenza A and B viruses cause annual influenza epidemics, whereas" exact="influenza" post="A viruses can also cause sporadic infections or spread"/>
  <result pre="antiviral spectrum of EEC against different types and subtypes of" exact="influenza" post="viruses, we infected A549 cells with 0.25 MOI of"/>
  <result pre="influenza viruses, we infected A549 cells with 0.25 MOI of" exact="influenza" post="A/Puerto Rico/8/1934, A/Puerto Rico/8/1934 (H274Y), A/human/Hubei/1/2009 (H1N1), A/human/Hubei/3/2005 (H3N2),"/>
  <result pre="diluted EEC. We found that EEC could inhibit all the" exact="influenza" post="viruses, including the oseltamivir-resistant H1N1 (H274Y) virus, on A549"/>
  <result pre="a similar efficiency (Figure 2). During infection of humans, the" exact="influenza" post="virus can infect multiple cell types, including epithelial cells"/>
  <result pre="cells and monocytes that are important for the pathogenesis of" exact="influenza" post="[24]. We next checked the antiviral effect of EEC"/>
  <result pre="on epithelial MDCK cells and monocytic U937 cells against both" exact="influenza" post="virus A and B viruses. Surprisingly, EEC was found"/>
  <result pre="B viruses. Surprisingly, EEC was found to inhibit all the" exact="influenza" post="virus strains both in MDCK cells and U937 cells."/>
  <result pre="canine MDCK cells, EEC inhibits more efficiently the replication of" exact="influenza" post="viruses in human A549 and U937 cells (Table 1)."/>
  <result pre="Influenza Virus Life Cycle To determine the stage of the" exact="influenza" post="virus life cycle inhibited by EEC, a time-of-addition assay"/>
  <result pre="was conducted. MDCK cells were infected with 0.1 MOI of" exact="influenza" post="virus at 4 °C for 1 h, followed by"/>
  <result pre="that EEC may inhibit the very late stage of the" exact="influenza" post="virus life cycle, which includes mainly the release of"/>
  <result pre="results show that EEC inhibits the late stage of the" exact="influenza" post="virus life cycle. Since the virus neuraminidase activity is"/>
  <result pre="virions, we speculate that EEC may inhibit the release of" exact="influenza" post="viruses. 3.4. EEC Protects Mice from Lethal Influenza Virus"/>
  <result pre="infection. These observations suggest that EEC protects mice from lethal" exact="influenza" post="virus infection. 3.5. EEC Reduces Virus Titer and Pathogenic"/>
  <result pre="the selective indexes of EEC in the inhibitory effects against" exact="influenza" post="virus A and B strains in human A549 and"/>
  <result pre="to 52 (Table 1), EEC does protect mice from lethal" exact="influenza" post="virus infection. To confirm whether EEC inhibits virus replication"/>
  <result pre="of the placebo group. When mice are infected with the" exact="influenza" post="virus, a large number of inflammatory cells are often"/>
  <result pre="pathological changes in the lungs of mice infected by lethal" exact="influenza" post="and treated or untreated with EEC, the total cell"/>
  <result pre="mediated by the antiviral effect of EEC. 4. Discussion/Conclusions Seasonal" exact="influenza" post="is an acute respiratory infection caused by influenza viruses"/>
  <result pre="Discussion/Conclusions Seasonal influenza is an acute respiratory infection caused by" exact="influenza" post="viruses that circulate the world [27]. Influenza A and"/>
  <result pre="disease. Currently circulating in humans are subtype A(H1N1) and A(H3N2)" exact="influenza" post="viruses [28]. Influenza viruses circulating in animals, e.g., birds,"/>
  <result pre="to infect humans and cause illness [29]. In patients with" exact="influenza" post="pneumonia, multiple cell types, including epithelial cells, alveolar cells,"/>
  <result pre="epithelial cells, alveolar cells, and monocytes, are infected by the" exact="influenza" post="virus and contribute to direct cytopathogenic and inflammatory damage"/>
  <result pre="tested the antiviral effect of EEC against a panel of" exact="influenza" post="viruses on the epithelial A549 cells and monocytic U937"/>
  <result pre="to that of ribavirin (Figure S1). In addition to human" exact="influenza" post="A viruses H1N1 and H3N2, human influenza B virus"/>
  <result pre="addition to human influenza A viruses H1N1 and H3N2, human" exact="influenza" post="B virus strains, the 2009 (H1N1) pandemic strain, oseltamivir-resistant"/>
  <result pre="the therapeutic effect of EEC was tested on a mouse" exact="influenza" post="model. Our results demonstrated that EEC protected mice from"/>
  <result pre="model. Our results demonstrated that EEC protected mice from lethal" exact="influenza" post="infection by increasing the survival rate that is associated"/>
  <result pre="total alkaloid extract from Commelina communis showed antiviral activity against" exact="influenza" post="virus H1N1 in vivo [33]. Utsunomiya et al. found"/>
  <result pre="production by T cells. Glycyrrhizin, by itself, does not inhibit" exact="influenza" post="virus replication [34]. Compared with these reported herb medicines,"/>
  <result pre="found at https://www.mdpi.com/1999-4915/12/5/557/s1. Figure S1: Antiviral effects of ribavirin against" exact="influenza" post="virus PR 8 were determined in A 549 U"/>
  <result pre="analysis of the TCID 50 and neuraminidase (NA) activity of" exact="influenza" post="virus solutions produced in cell culture. LINK Click here"/>
  <result pre="respiratory mortality: A modelling studyLancet20183911285130010.1016/S0140-6736(17)33293-229248255 2.KrammerF.The human antibody response to" exact="influenza" post="A virus infection and vaccinationNat. Rev. Immunol.20191938339710.1038/s41577-019-0143-630837674 3.YamayoshiS.KawaokaY.Current and"/>
  <result pre="A virus infection and vaccinationNat. Rev. Immunol.20191938339710.1038/s41577-019-0143-630837674 3.YamayoshiS.KawaokaY.Current and future" exact="influenza" post="vaccinesNat. Med.20192521222010.1038/s41591-018-0340-z30692696 4.DarwishI.MubarekaS.LilesW.C.Immunomodulatory therapy for severe influenzaExpert Rev Anti-Infect."/>
  <result pre="5.DunningJ.BaillieJ.K.CaoB.HaydenF.G.Antiviral combinations for severe influenzaLancet Infect. Dis.2014141259127010.1016/S1473-3099(14)70821-725213733 6.JeffersonT.DemicheliV.RivettiD.JonesM.Di PietrantonjC.RivettiA.Antivirals for" exact="influenza" post="in healthy adults: Systematic reviewLancet200636730331310.1016/S0140-6736(06)67970-116443037 7.Van DongenM.J.P.KadamR.U.JuraszekJ.LawsonE.BrandenburgB.SchmitzF.WilsonI.A.A small-molecule fusion"/>
  <result pre="healthy adults: Systematic reviewLancet200636730331310.1016/S0140-6736(06)67970-116443037 7.Van DongenM.J.P.KadamR.U.JuraszekJ.LawsonE.BrandenburgB.SchmitzF.WilsonI.A.A small-molecule fusion inhibitor of" exact="influenza" post="virus is orally active in miceScience2019363pii:eaar622110.1126/science.aar6221 8.NaesensL.StevaertA.VanderlindenE.Antiviral therapies on"/>
  <result pre="the horizon for influenzaCurr. Opin. Pharmacol.20163010611510.1016/j.coph.2016.08.00327570127 9.PaulesC.SubbaraoK.InfluenzaLancet201739069770810.1016/S0140-6736(17)30129-028302313 10.ShinyaO.ValentinaS.TakashiH.TakeshiN.HirotoY.MakotoK.KeikoK.TakekiU.TakaoS.AkiraN.et al.Characterization of" exact="influenza" post="virus variants induced by treatment with the endonuclease inhibitor"/>
  <result pre="J. Med.201837991392310.1056/NEJMoa171619730184455 12.HurtA.C.The epidemiology and spread of drug resistant human" exact="influenza" post="virusesCurr. Opin. Virol.20148222910.1016/j.coviro.2014.04.00924866471 13.HanX.ZhangD.-K.GuoY.-M.FengW.-W.DongQ.ZhangC.-E.ZhouY.-F.LiuY.WangJ.-B.ZhaoY.-L.et al.Screening and evaluation of commonly-used"/>
  <result pre="Influenza Viruses of Animals and HumansSpringerCham, Switzerland2014 25.IwasakiA.PillaiP.Innate immunity to" exact="influenza" post="virus infectionNat. Rev. Immunol.20141431532810.1038/nri366524762827 26.ShortK.KroezeE.FouchierR.KuikenT.Pathogenesis of influenza-induced acute respiratory"/>
  <result pre="al.Tissue tropisms opt for transmissible reassortants during avian and swine" exact="influenza" post="A virus co-infection in swinePLoS Pathog.201814e100741710.1371/journal.ppat.100741730507946 30.LiuQ.ZhouY.-H.YangZ.-Q.The cytokine storm"/>
  <result pre="virus co-infection in swinePLoS Pathog.201814e100741710.1371/journal.ppat.100741730507946 30.LiuQ.ZhouY.-H.YangZ.-Q.The cytokine storm of severe" exact="influenza" post="and development of immunomodulatory therapyCell. Mol. Immunol.20151331010.1038/cmi.2015.7426189369 31.PeirisJ.S.HuiK.YenH.-L.Host response"/>
  <result pre="and development of immunomodulatory therapyCell. Mol. Immunol.20151331010.1038/cmi.2015.7426189369 31.PeirisJ.S.HuiK.YenH.-L.Host response to" exact="influenza" post="virus: Protection versus immunopathologyCurr. Opin. Immunol.20102247548110.1016/j.coi.2010.06.00320594815 32.ChonH.Chapter 11—Medicinal Herbs"/>
  <result pre="Agents Chemother19974155155610.1128/AAC.41.3.5519055991 Figure 1 Caesalpinia decapetala (Roth) Alston (EEC) inhibits" exact="influenza" post="virus replication in A549 cells. A549 cells were infected"/>
  <result pre="virus replication in A549 cells. A549 cells were infected with" exact="influenza" post="virus A/Puerto Rico/8/1934 (H1N1) at an multiplicity of infection"/>
  <result pre="2 EEC has a broad spectrum of antiviral activities against" exact="influenza" post="viruses in A549 cells. A549 cells were infected with"/>
  <result pre="influenza viruses in A549 cells. A549 cells were infected with" exact="influenza" post="viruses A/Puerto Rico/8/1934 (H1N1), A/Puerto Rico/8/1934 (H1N1, H274Y oseltamivir-resistant),"/>
  <result pre="activity assay, respectively. The dose-response curves of EEC against different" exact="influenza" post="viruses were made using Prism software (GraphPad Software, San"/>
  <result pre="USA). Figure 3 EEC affects the late stage of the" exact="influenza" post="virus life cycle by inhibiting neuraminidase activity. The stages"/>
  <result pre="life cycle by inhibiting neuraminidase activity. The stages of the" exact="influenza" post="virus life cycle affected by EEC were determined by"/>
  <result pre="(PerkinElmer, MA, USA). Figure 4 EEC protects mice from lethal" exact="influenza" post="virus infection. Six-week-old female BALB/c mice weighing 16–18 g"/>
  <result pre="200 μm) (G). viruses-12-00557-t001_Table 1Table 1 Inhibition of 6 different" exact="influenza" post="virus strains in A549, Madin–Darby Canine Kidney (MDCK), and"/>
 </snippets>
</snippetsTree>
